We accelerate the digitization and transformation of the world
through breakthrough technologies.
VYTE Investment · Byte Velocity
VYTE believes in the velocity at which technology reshapes the world. We are a thesis-driven firm concentrated on deep tech and AI — partnering early, staying long, and going deep with the most audacious teams.
We invest across the broad landscape of deep tech, seeking opportunities where technology dismantles industry boundaries and creates entirely new categories at scale.
We are drawn to teams that drive rapid, compounding innovation through AI — those who combine deep technical conviction with relentless execution at byte velocity.
With deep domain knowledge forged at the frontier of AI medical devices, we support teams transforming healthcare access, diagnostics, and patient outcomes through technology.
Regardless of domain, we back every team that builds from a foundation of technology. What draws us is the depth of thinking and the boldness of the mission.
We invest in teams who move fast and think deeply. Each company in our portfolio represents a conviction that technology can fundamentally reshape its industry.
A platform that makes AI medical services accessible to every healthcare institution — without barriers. Democratizing medical AI so that every clinic and hospital can harness the power of artificial intelligence.
Nature-inspired patches validated by peer-reviewed academic research. Biomimicry technology engineered at the molecular level — opening new frontiers at the intersection of medicine, materials science, and industry.
An AI-powered automated futures trading robo-advisor. Applying deep learning to financial markets — redefining how algorithmic intelligence navigates volatility, executes strategy, and generates alpha in real time.
An AI-based portable spirometer that simultaneously achieves miniaturization and clinical-grade intelligence in precision pulmonary diagnostics — bringing hospital-level respiratory testing to any point of care.
A pioneer at the intersection of artificial intelligence and medicine, Hyun-Jun co-founded VUNO — the Republic of Korea's first AI medical device manufacturer — and served as CEO through its foundational years, securing the nation's first regulatory approval for an AI-powered medical device. His work at VUNO established the blueprint for clinical AI commercialization in Korea and opened the door for an entire generation of medical AI companies.
Drawing on this rare combination of deep technical expertise, regulatory navigation, and venture-scale execution, he now leads VYTE Investment — backing the next wave of technology founders building at byte velocity.